🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is open to adults with diabetic macular edema that involves the ...
Status
Recruiting
Location
Associated Retina Consultants, Ltd.
Start Date
2026-05-14
Trial ID
NCT07553429
Treatments Being Tested
This is a global, multicenter, randomized, open-label, Phase 2/3 study of D...
Status
Recruiting
Location
Research Site
Start Date
2025-09-26
Trial ID
NCT07129993
Treatments Being Tested
This trial will look at a drug called SEA-CD70 with and without azacitidine...
Status
Recruiting
Location
University of Alabama at Birmingham
Start Date
2020-08-07
Trial ID
NCT04227847
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of rocatin...
Status
Completed
Location
Cahaba Dermatology and Skin Health Center
Start Date
2023-04-20
Trial ID
NCT05704738
Treatments Being Tested
A study evaluating efficacy and safety of repeated doses of PT027 compared ...
Status
Completed
Location
Research Site
Start Date
2022-09-28
Trial ID
NCT05555290
To investigate safety, tolerability, pharmacokinetics, pharmacodynamics and...
Status
Completed
Location
Fukuoka Clinical Site
Start Date
2019-09-12
Trial ID
NCT04079062
Treatments Being Tested
We hypothesized that a portion controlled diet would prevent the weight gai...
Status
Completed
Location
Pennington Center
Start Date
2003-02
Trial ID
NCT00219440
Treatments Being Tested
The Phase 1 study described herein will evaluate the safety, tolerability, ...
Status
Recruiting
Location
Xencor Investigative Site
Start Date
2024-10-10
Trial ID
NCT06619990
This study aims to see how the body reacts to empasiprubart, administered u...
Status
Recruiting
Location
Altasciences
Start Date
2026-03-16
Trial ID
NCT07612020
Treatments Being Tested
This study will be a two-part with an open-label, single oral dose, two-way...
Status
Completed
Location
GSK Investigational Site
Start Date
2015-02-11
Trial ID
NCT02371603